Contact
Please use this form to send email to PR contact of this press release:
Immune Design Announces G100’s Receipt of Orphan Drug Designation by the EMA for the Treatment of Follicular Non-Hodgkin’s Lymphoma
TO:
Please use this form to send email to PR contact of this press release:
Immune Design Announces G100’s Receipt of Orphan Drug Designation by the EMA for the Treatment of Follicular Non-Hodgkin’s Lymphoma
TO: